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Decay of eukaryotic mRNAs can be triggered by poly(A) shortening, endonucleolytic cleavage, or aberrant translation (for a review, see reference 16). Aberrant translation includes nonsense-mediated mRNA decay, the rapid turnover of an otherwise stable mRNA that ensues when a ribosome encounters a premature translational termination codon. This phenomenon has been observed in both prokaryotic and eukaryotic cells but has been best characterized for Saccharomyces cerevisiae (for reviews, see references 16 and 27) . In the yeast system this type of mRNA decay is cytoplasmic and depends on, in addition to a nonsense codon, at least two cis-acting coding-region sequences and several trans-acting factors (27) . The coding-region sequences include a site 3Ј to the nonsense codon that appears to promote translational reinitiation and messenger ribonucleoprotein (mRNP) conformational changes and a sequence that, when translated, inactivates a ribosome's capacity to promote rapid mRNA decay (10a, 16, 25, 40) .
trans-acting factors required for nonsense-mediated mRNA decay were initially identified by a genetic screen for allosuppressors of the his4-38 frameshift allele (6) . Subsequent screens that also identified components of this pathway included those seeking mutations that increased frameshifting efficiencies (8, 20) , suppressors of upstream initiation codons (28) , and omnipotent suppressors (41) . Complementation of these mutants, or the use of two-hybrid screens, led to the isolation of the nonessential UPF1 (IFS2/SAL2/MOF4), NMD2 (UPF2/SUA1/IFS1), and UPF3 (SUA6) genes and to the demonstration that mutations in these genes cause stabilization and increased accumulation of nonsense-containing mRNAs while having no effect on the stabilities or abundances of most wildtype transcripts (5, 12, 13, (19) (20) (21) 25) .
Of the trans-acting factors identified by these approaches, that encoded by the UPF1 gene has been studied most extensively. The UPF1 gene encodes a protein that has a predicted molecular mass of 109 kDa, two putative Zn 2ϩ fingers near its N terminus, and seven conserved motifs common to the members of helicase superfamily I (1, 18, 22) . Upf1p is localized primarily in the cytoplasm and appears to be polyribosome associated (3, 26) . Upf1p has recently been purified from yeast cells and shown to possess nucleic acid-binding activity as well as nucleic acid-dependent ATPase and helicase activities (7) . Characterization of the NMD2 gene indicates that it encodes an acidic protein with a predicted molecular mass of 127 kDa and no significant homologies to other polypeptides (5, 12) . Two-hybrid analyses demonstrate that Nmd2p and Upf1p are interacting proteins and that the Upf1p-interacting domain of Nmd2p is localized within a 157-amino-acid segment at its C terminus (14) . Mutations in this domain that disrupt interaction with Upf1p also inactivate nonsense-mediated mRNA decay, indicating that Upf1p-Nmd2p interaction is required for function of this decay pathway (14) . The UPF3 gene encodes a basic protein with a predicted molecular mass of 45 kDa (19) . Upf3p has no significant homologies to other proteins, but, like Nmd2p (12) , Upf3p contains multiple lysine-arginine-rich sequences that resemble bipartite nuclear localization sequences known to target proteins to the nucleus (19) .
Although the identification and initial characterization of Upf1p, Nmd2p, and Upf3p have provided insight into the mechanism of nonsense-mediated mRNA decay, the precise functions and interactions of these factors are largely unknown. Given that single disruptions of UPF1, NMD2, and UPF3 inhibit nonsense-mediated mRNA decay to the same extent, and that double disruptions are not additive, it appears that Upf1p, Nmd2p, and Upf3p may function as a complex or in closely related steps of this mRNA decay pathway (5, 12, 19, 37) . Except for the interaction between Upf1p and Nmd2p (12, 14) , interactions between these factors have not been characterized extensively. To address this problem, we have used the yeast two-hybrid system to identify genes encoding Nmd2p-interacting proteins, to characterize the specific domains involved in Upf1p-Nmd2p and Nmd2p-Upf3p interactions, and to show that Nmd2p can interact with both Upf1p and Upf3p simultaneously, possibly promoting the formation of a Upf1p-Nmd2p-Upf3p complex in vivo. Our two-hybrid studies and the analysis of mRNA decay in strains with one or more of these factors deleted as well as in strains harboring a dominantnegative NMD2 allele lead us to conclude that Upf1p, Nmd2p, Upf3p, and at least one other factor are interacting components of the nonsense-mediated mRNA decay pathway.
GAA TCC GGG, in which the EcoRI site is in the same reading frame as that of pMA424, pBTM116, and pGAD-C1, pGAD-C2, and pGAD-C3.
(ii) lexA(DB)-NMD2 fusion constructs. The plasmid pHF1186 (Table 4) was used for the two-hybrid screen. It carries a lexA(DB)-NMD2 DN (326-1089) fusion and was constructed as follows. A 210-bp PCR-derived EcoRI-ClaI fragment (from codon 326 to the ClaI site in the NMD2 coding region) was ligated into Bluescript KS(ϩ) digested previously with EcoRI and ClaI. The resulting plasmid, pHF1201 (Table 3) , was then digested with ClaI and SalI and ligated to a 3.5-kb ClaI-SalI NMD2 fragment isolated from pRS316-HA-NMD2(X-S) (14) , creating pHF1203. A 5Ј-end 1,339-bp EcoRI-PstI fragment and a 3Ј-end 2.4-kb PstI-SalI fragment were individually isolated from pHF1203 and were ligated into pBTM116 digested previously with EcoRI and SalI in a three-fragment ligation reaction.
The plasmid pHF1268, which carries a lexA(DB)-NMD2 fusion containing an N-terminal deletion up to residue 772, was constructed by ligating a 2.3-kb EcoRI-SalI fragment isolated from pHF1186 into pBTM116 digested previously with EcoRI and SalI. The plasmids pHF1308, pHF1309, pHF1311, and pHF1313, which carry lexA(DB)-NMD2 fusions containing N-terminal deletions up to residues 473, 564, 638, and 693, respectively, were constructed by using pHF1268. In each case, a pair of oligonucleotide primers containing either EcoRI/BamHI sites (5Ј primer) or an EcoRI site (3Ј primer, NMD2-M11) were used for amplification (Table 1 ) (14) . The PCR-amplified fragment was digested with EcoRI and ligated into pHF1268 digested previously with EcoRI. The correct orientation of each insert was confirmed by restriction digestion. The plasmids pHF1304 and pHF1306, which carry lexA(DB)-NMD2 fusions containing N-terminal deletions up to residues 817 and 879, respectively, were constructed by using PCR-derived fragments. The oligonucleotide primer pairs NMD2-TH29/NMD2-M10 and NMD2-TH30/NMD2-M10 were used for amplification (Table 1 ) (14) . The PCR-amplified fragments were digested with EcoRI and SalI and ligated individually into pBTM116 digested previously with EcoRI and SalI. Plasmid pHF1270, which carries a lexA(DB)-NMD2 fusion containing an N-terminal deletion up to residue 933, was constructed by ligating the 1.1-kb EcoRI-SalI fragment isolated from pHF1050 (see below) into pBTM116 digested previously with EcoRI and SalI.
The plasmids pHF1262, pHF1264, pHF1266, pHF1352, pHF1349, pHF1348, pHF1345, and pHF1344 carry lexA(DB)-NMD2 fusions with distinct C-terminal deletions and were constructed by using pHF1186. In each case, a ClaI-SalI fragment from the C-terminal region of the individual HA-nmd2 alleles that harbor distinct C-terminal deletions (see below and Table 3 ) was isolated and ligated into pHF1186 digested previously with ClaI and SalI. The plasmids pHF1467, pHF1469, pHF1471, and pHF1473 carry lexA(DB)-NMD2(564-923), lexA(DB)-NMD2(564-883), lexA(DB)-NMD2(564-816), and lexA(DB)-NMD2 (564-803) fusions, respectively. They were constructed by ligating a 630-bp EcoRI-EcoRI fragment (from codon 564 to the EcoRI site in the coding region of pHF1309-borne NMD2) into pHF1262, pHF1264, pHF1266, and pHF1352 digested previously with EcoRI. The plasmids pHF1528 and pHF1530, which carry lexA(DB)-NMD2(564-771) and lexA(DB)-NMD2(564-692) fusions, respectively, were constructed by the following three-fragment ligations: a PCR-amplified EcoRI-BglII fragment and a 0.6-kb BglII-SalI fragment isolated from pHF926 were ligated into pBTM116 digested previously with EcoRI and SalI. The oligonucleotide pairs NMD2-TH25/NMD2-TH31 and NMD2-TH25/NMD2-TH32 (Table 1) were used for amplification of the respective fragments.
(iii) GAL4(DB)-NMD2 and GAL4(AD)-NMD2 fusion constructs. The plasmid pHF1050, which carries the GAL4(DB)-NMD2(933-1089) fusion, was used for mapping the Nmd2p-interacting domain of Upf1p. It was constructed by ligating a PCR-amplified EcoRI-SalI fragment into pMA424 digested previously with EcoRI and SalI. The oligonucleotides NMD2-TH18 and NMD2-M10 were used for PCR amplification (Table 1) (14) .
The plasmids pHF1415, pHF1417, pHF1419, pHF1421, pHF1425, and pHF1427, which carry GAL4(AD)-NMD2 fusions containing N-terminal deletions up to residues 473, 564, 638, 693, 817, and 879, respectively, and the plasmids pHF1670, pHF1672, pHF1674, pHF1676, pHF1534, and pHF1536, which carry GAL4(AD)-NMD2 fusions each containing an internal fragment beginning at codon 564, were constructed in the same way. In each case, a BamHI-SalI fragment was isolated from the corresponding lexA(DB)-NMD2 fusion plasmid (Table 4 ) and ligated into pGAD-C1 digested previously with BamHI and SalI. The plasmid pHF1423, which carries the GAL4(AD)-NMD2(772-1089) fusion, was constructed by ligating a PCR-amplified BamHISalI fragment into pGAD-C1 digested previously with BamHI and SalI. The oligonucleotides NMD2-TH28 and NMD2-M10 were used for PCR amplification. The plasmids pHF1429 and pHF1431, which carry the GAL4(AD)-NMD2(933-1089) and GAL4(AD)-NMD2(326-563) fusions, respectively, were constructed by ligating EcoRI-SalI fragments isolated from pHF1050 and pHF1344, respectively, into pGAD-C1 digested previously with EcoRI and SalI. The plasmid pHF1441, which carries a GAL4(AD)-NMD2 fusion with the original dominant-negative fragment encoding Nmd2p residues 326 to 1089 (12) , and the plasmids pHF1458, pHF1456, pHF1454, pHF1452, pHF1450, pHF1448, and pHF1446, which carry GAL4(AD)-NMD2 fusions each containing a distinct C-terminal deletion, were constructed by using pHF1431. In each case, a ClaISalI fragment from the C-terminal regions of the individual HA-nmd2 alleles, each harboring a distinct C-terminal deletion (Table 3) , was isolated and ligated into pHF1431 digested previously with ClaI and SalI.
(iv) lexA(DB)-UPF3 and GAL4(AD)-UPF3 fusion constructs. All lexA(DB)-UPF3 fusions used for mapping the Nmd2p-and Upf1p-interacting domains of Upf3p were constructed by using PCR-derived fragments. In each case, a pair of oligonucleotide primers containing either a BamHI site (5Ј primer) or a SalI site (3Ј primer) were used for amplification ( Table 1) . The PCR-amplified fragment was digested with BamHI and SalI and ligated into pBTM116 digested previously with BamHI and SalI. The resulting plasmids each carried a distinct fragment from the UPF3 coding region ( (vi) Construction of upf1::HIS3, upf1-1::URA3, nmd2::URA3, and upf3::HIS3 alleles. The plasmids pHF1395 and pHF1397, which carry the upf1::HIS3 and upf1-1::URA3 alleles, respectively, were constructed in two steps. First, a 401-bp PCR-derived EcoRI-BglII fragment containing the promoter and 5Ј untranslated region (5Ј-UTR) of UPF1 and a 449-bp PCR-derived BglII-SalI fragment containing sequences 3Ј to the translational stop codon of UPF1 were ligated into Bluescript digested previously with EcoRI and SalI. The oligonucleotide pairs UPF1-DS1/UPF1-DS2 and UPF1-DS3/UPF1-DS4 were used for PCR amplification of the two fragments, respectively, and this three-fragment ligation reaction generated pHF1390. Second, a 1.8-kb BamHI-BamHI HIS3 fragment or a 1.2-kb BamHI-ClaI URA3 fragment was ligated into pHF1390 digested previously with BglII or BglII and ClaI, respectively. This led to a replacement of the entire UPF1 coding region by either the HIS3 or URA3 gene. The plasmid pHF275, which carries the nmd2::URA3 allele, was also constructed in two steps. First, a 1.1-kb XbaI-BamHI fragment containing the promoter, the 5Ј-UTR, and a portion of the N-terminal coding sequences of NMD2 was isolated from pRS315-NMD2(X-S) (14) and ligated into Bluescript digested previously with XbaI and BamHI, generating Bs-NMD2(X-B). Second, a 1.2-kb BamHI-ClaI URA3 fragment and a 1.1-kb ClaI-EcoRI fragment from the NMD2 coding region were ligated into Bs-NMD2(X-B) digested previously with BamHI and EcoRI. This led to a replacement of the NMD2 coding region from the BamHI site to the ClaI site by the URA3 gene. Plasmid pHF1409, carrying the upf3::HIS3 allele, was constructed in the same way as pHF1395 except that a 433-bp PCR-derived XbaI-BglII fragment (containing the promoter and 5Ј-UTR of UPF3) and a 381-bp PCR-derived BglII-SalI fragment (containing sequences 3Ј to the translational stop codon of UPF3) were ligated into Bluescript digested previously with XbaI and SalI in a three-fragment ligation reaction, generating pHF1286. The oligonucleotide pairs UPF3-1/UPF3-8 and UPF3-9/UPF3-10 were used for PCR amplification of the respective fragments.
(vii) NMD2-containing plasmids. The plasmids pHF1207 and pHF1206, which carry HA-nmd2 alleles encoding C-terminal Nmd2p deletions of 206 and 273 residues, respectively, were constructed by using pHF926 (14) . In either case, a PCR-derived EcoRI-BglII fragment was ligated into pHF926 digested previously with EcoRI and BglII. This led to a replacement of the wild-type NMD2 fragment (from the EcoRI site in the coding region to the translation stop codon) by a C-terminally truncated one. The oligonucleotide pairs NMD2-M11/NMD2-TH23 and NMD2-M11/NMD2-TH22 were used for PCR amplification of the respective fragments. The plasmids pHF1342, pHF1301, pHF1338, pHF1298, and pHF1296, which carry HA-nmd2 alleles containing C-terminal deletions of 286, 318, 397, 452, and 526 codons, respectively, were constructed in the same way as pHF1207 and pHF1206. In each case, a PCR-derived ClaI-BglII fragment was ligated into pHF926 digested previously with ClaI and BglII. This led to a replacement of the wild-type NMD2 fragment (from the ClaI site in the coding region to the translation stop codon) by a C-terminally truncated one. The oligonucleotide pairs hf21Ј-1/NMD2-TH5, hf21Ј-1/NMD2-TH31, hf21Ј-1/NMD2-TH32, hf21Ј-1/NMD2-TH33, and hf21Ј-1/NMD2-TH34 were used for amplification (Table 1) (14) . The plasmid pHF1569, which carries the HA-nmd2(564-1089) allele, was constructed in two steps. First, the XbaI-SalI fragment containing the HA-nmd2-N⌬771 allele was isolated from pHF692 (14) and ligated into pRS316, generating pHF1520. Second, an EcoRI-EcoRI fragment containing NMD2 sequences from codon 564 to the EcoRI site in the coding region was isolated from pHF1309 and ligated into pHF1520 digested previously by EcoRI. The plasmid pHF1085, which carries an ADH1 promoter-driven HA-NMD2 allele, was constructed by ligating a 431-bp PCR-amplified XbaI-NcoI fragment, containing the promoter and 5Ј-UTR of the ADH1 gene, into YEplac112-HA-NMD2(X-S) (12) digested previously with XbaI and NcoI. This led VOL. 17, 1997 INTERACTIONS BETWEEN mRNA DECAY FACTORSto a replacement of the NMD2 promoter region by that of ADH1. The oligonucleotides ADH1p-XbaI and ADH1p-NcoI (Table 1) were used for PCR amplification. The plasmids pHF1628, pHF1629, pHF1630, and pHF1648, which carry the ADH1 promoter-driven HA-NMD2, HA-nmd2-C⌬166, HA-nmd2-C⌬526, and HA-nmd2(564-1089) alleles, respectively, were constructed by three-fragment ligations. In each case, a 431-bp XbaI-NcoI fragment (containing the ADH1 promoter region) isolated from pHF1085 and an NcoI-SalI fragment (containing the respective NMD2 alleles) isolated from pHF1085, pHF707 (14) , pHF1296, and pHF1569, were ligated into pRS313 digested previously with XbaI and SalI.
(viii) UPF3-containing plasmids. Plasmid pHF1427, which carries a wild-type UPF3 gene, was constructed by a three-fragment ligation. A PCR-derived XbaISnaBI fragment (containing 427 bp of the promoter region and 559 bp of the N-terminal portion of the UPF3 coding region) and a 2.0-kb SnaBI-SalI fragment (containing sequences including the C-terminal portion of the UPF3 coding region and the 3Ј-UTR region), isolated from pHF1686, were ligated into YEplac112 digested previously with XbaI and SalI. The oligonucleotide primers UPF3-1 and UPF3-3 were used in PCR amplification. Plasmids pHF1288 and pHF1292 both carry the wild-type UPF3 gene and were constructed by ligating either a BamHI-SalI or an XbaI-SalI fragment isolated from pHF1427 into pRS314 or pRS316 digested previously with either BamHI and SalI or XbaI and SalI, respectively. The plasmid pHF1385, which carries a FLAG-UPF3 allele, was constructed by using pHF1292. A PCR-derived XbaI-NcoI fragment (containing the UPF3 promoter region) and a PCR-derived NcoI-HindIII fragment (containing the FLAG epitope and an N-terminal portion of the UPF3 coding region) GAL4(AD) . Transformants were grown for 10 h in synthetic liquid medium lacking tryptophan and leucine to maintain selection for the lexA-NMD2 DN (326-1089) fusion plasmid and the library plasmid, respectively. The transformants were then plated on synthetic medium lacking histidine, tryptophan, and leucine and containing 5 mM 3-aminotriazole. After 4 to 6 days of growth on plates at 30ЊC, His ϩ transformants were replica plated to X-Gal (5-bromo-4-chloro-3-indolyl-␤-Dgalactopyranoside) plates and were incubated until blue colonies appeared. Library plasmids were recovered from blue colonies as previously described (12) . To test for specificity, isolated library plasmids were individually retransformed into the original L40 strain with either (i) the lexA(DB)-NMD2 DN fusion, (ii) a series of the lexA(DB)-NMD2 DN fusions containing deletions from the C terminus, or (iii) the lexA(DB) vector only. The plasmids encoding Nmd2 DN p-interacting proteins were characterized further by sequence analysis. DNA sequences were compared to existing sequence databases by using the BlastN program (2) .
Two-hybrid interaction assay. The two-hybrid tester strain GGY1::171 was used to assay interactions between Upf1p and Nmd2p. The two-hybrid tester strain L40 was used to assay interactions between Nmd2p and Upf3p and between Upf1p and Upf3p. In each case, a GAL4(DB) or lexA(DB) fusion construct (Table 4) was cotransformed with a GAL4(AD) construct into the tester strain. Transformants were incubated for 3 to 5 days at 30ЊC until colonies were fairly large. Both qualitative and quantitative assays for ␤-galactosidase activity were performed as previously described (14, 24) . Cells harboring each of the pGAD-C1, pGAD-C2, pACTII, pMA424, and pBTM116 vectors produced Ͻ0.05 U of ␤-galactosidase activity. Values for ␤-galactosidase assays represent the means for at least three independent transformants. Standard deviations are indicated.
RNA preparation and Northern analysis. RNA preparation and Northern analysis were performed as previously described (14) . The ratio of CYH2 premRNA to mRNA was used as an index of the activity of the nonsense-mediated mRNA decay pathway (12) (13) (14) . The values presented represent averages from at least two independent experiments.
Western blot analysis. Western blot analyses, performed as previously described (14) , were used to monitor fusion protein expression levels. An antihemagglutinin (anti-HA) monoclonal antibody (12CA5; Boehringer) was diluted 1:1,000. Horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G-immunoglobulin M (heavy plus light chains) was diluted 1:5,000. Bound antibodies were detected with the enhanced chemiluminescence system (Amersham) used according to the manufacturer's instructions.
RESULTS
Identification of Upf1p and Upf3p as proteins that interact with a dominant-negative fragment of Nmd2p. We previously demonstrated that overexpression of a GAL4(AD) fusion to a 764-amino-acid C-terminal fragment of Nmd2p (Nmd2 DN p) inhibits the nonsense-mediated mRNA decay pathway in a dominant manner when the fusion protein is localized to the cytoplasm but not when it is localized to the nucleus (12). Amino acid substitutions or deletions in the Upf1p-interacting domain of this protein do not affect dominant-negative inhibition of mRNA decay, suggesting that Nmd2 DN p interacts not only with Upf1p but also with at least one additional factor (14) . To identify potential Nmd2 DN p-interacting factors, we used the yeast two-hybrid system (10, 39) . DNA encoding the dominant-negative NMD2 DN allele was inserted into a yeast expression vector in frame with a sequence encoding the DNAbinding domain of the lexA protein. This plasmid was introduced into the yeast strain L40 (15) , which harbors the HIS3 and lacZ genes under the control of promoters containing the lexA-binding site. Yeast genomic DNA libraries fused, in three separate frames, to sequences encoding the Gal4p transcriptional activation domain were then screened for cotransforming plasmids which allow the L40 cells to express these two reporter genes.
Approximately 3 ϫ 10 6 independent transformants were screened, and 90 colonies that grew in the absence of histidine and in the presence of 5 mM 3-aminotriazole and exhibited ␤-galactosidase activity were isolated. The library plasmids from these colonies were rescued and tested for specificity by retransforming them into the original L40 strain simultaneously with either (i) the lexA(DB)-NMD2 DN fusion, (ii) a series of the lexA(DB)-NMD2 DN fusions containing deletions from the C terminus, or (iii) the lexA(DB) vector only. Restriction mapping and partial DNA sequence analysis of plasmids which passed these specificity tests yielded seven different genes encoding putative Nmd2 DN p-interacting proteins. One class of clones, as we expected, encoded near-full-length Upf1p, and a second class of clones encoded a fragment of 236 amino acids from the C terminus of Upf3p (19) . The other five classes of clones encoded either previously identified genes (SPP41 and RED1) (23, 36) or uncharacterized open reading frames (YBR270c, YKL023w, and YNR023w). Deletion of RED1 does not affect nonsense-mediated mRNA decay (data not shown), and the roles of the other four genes have yet to be determined. In the experiments described below, we have characterized the interactions between the three principal components of the nonsense-mediated mRNA decay pathway, i.e., Upf1p, Nmd2p, and Upf3p.
Upf1p and Upf3p interact with distinct domains of Nmd2p. To determine the regions of Nmd2p responsible for interaction with Upf1p and Upf3p, we constructed a series of NMD2 deletions and tested their abilities to promote two-hybrid interactions with either UPF1 or UPF3. NMD2 fragments were fused in frame to the lexA(DB), and the full-length UPF1 and UPF3 genes were fused in frame to the GAL4(AD). The extent of interaction between the respective fusion proteins was monitored in cotransformants indirectly, by both a qualitative plate assay and a quantitative solution assay for ␤-galactosidase. These experiments established that coexpression of GAL4 (AD)-UPF1 with all of the lexA(DB)-NMD2 fusions that included the 157 C-terminal amino acids of Nmd2p led to the accumulation of substantial ␤-galactosidase activity (Fig. 1 , constructs 1 to 9), whereas coexpression of GAL4(AD)-UPF1 with all of the lexA(DB)-NMD2 fusions that lack 166 or more C-terminal amino acids from Nmd2p yielded background levels of ␤-galactosidase activity (Fig. 1, constructs 10 to 23 ). These results, and earlier studies using different DNA-binding domain and activation domain fusion constructs (14) , support our previous conclusion that Upf1p interacts with a 157-aminoacid C-terminal domain of Nmd2p (14) and demonstrate that Upf1p-Nmd2p two-hybrid interactions are independent of the nature of the DNA-binding domain and activation domain fusions utilized. The decreased levels of ␤-galactosidase activity obtained with three fusions that retain an intact Nmd2p C terminus (Fig. 1, constructs 2, 4 , and 5) are not indicative of additional Upf1p-interacting epitopes but rather reflect the instability of the respective fusion proteins (data not shown).
Cells coexpressing the full-length GAL4(AD)-UPF3 fusion and the lexA(DB)-NMD2
DN (326-1089) fusion accumulated substantially less ␤-galactosidase activity than the corresponding Nmd2p-Upf1p fusion pair but nevertheless accumulated sufficient activity to indicate interaction (Fig. 1, construct 1) . This activity doubled when amino acids 326 to 563 were deleted from Nmd2p (Fig. 1, construct 3) and was eliminated when the DNA-binding domain fusion included only amino acids 326 to 563 of Nmd2p (Fig. 1, construct 17) . These data suggest that the region of Nmd2p from residue 564 to 1089 must contain the entire Upf3p-interacting domain. To map this domain further, the consequences of both N-terminal and Cterminal deletions of Nmd2p were analyzed. The results obtained from this experiment indicate the following (i) Upf3p interacts with an Nmd2p domain that is distinct from the Upf1p-interacting domain, since a construct containing only the latter did not interact with Upf3p (Fig. 1, construct 9) and deletion of the Upf1p-interacting domain of Nmd2p had no effect on its interaction with Upf3p (Fig. 1 , constructs 10 and 18; compare to constructs 1 and 3). (ii) The region encompassed by Nmd2p residues 564 to 771 contains a major determinant for Upf3p interaction, since the lexA(DB)-NMD2(772-1089) fusion containing an N-terminal deletion from residue 564 to 771 led to a large decrease of ␤-galactosidase activity (Fig. 1, construct 6 ), the lexA(DB)-NMD2 fusions containing this region yielded substantial levels of ␤-galactosidase activity (Fig. 1, constructs 10 to 14 and 18 to 22) , and fusion proteins with C-terminal truncations of this region lost all detectable Upf3p interaction activity (Fig. 1, constructs 15 and 23) . The actual N-terminal boundary of this interacting domain could not be determined because two of the NMD2 fusion proteins (Fig. 1, constructs 4 and 5) were unstable, regardless of whether the fusions were to the lexA(DB) or the GAL4(AD) (data not shown). (iii) The region of Nmd2p from residue 879 to 933 that contains almost the entire acidic domain of Nmd2p (12, 14) contributes to Upf3p interaction, since deletion of this region from the respective fusion proteins leads to reduced levels of ␤-galactosidase activity (Fig. 1 , compare construct 10 to 11 and construct 18 to 19) and since the lexA(DB)-NMD2(879-1089) fusion yielded detectable levels of ␤-galactosidase activity (Fig. 1, construct 8) . (iv) The region of Nmd2p from residue 772 to 878 may not contribute to interaction with Upf3p, since N-or C-terminal deletions into this region had almost no effect on Nmd2p-Upf3p two-hybrid interaction (Fig.  1 , constructs 6 to 8, 11 to 14, and 19 to 22).
Interactions between Upf3p and Nmd2p were also examined in constructs in which the respective activation domain and DNA-binding domain fusions were reversed. In support of the conclusions delineated above, results qualitatively identical to those presented in Fig. 1 were obtained (data not shown) .
An internal domain of Upf3p encompassing residues 78 to 278 is the major determinant for interaction with Nmd2p. UPF3 was identified as a gene encoding an Nmd2 DN p-interacting protein (see above), and the respective Upf3p region(s) responsible for such interaction was determined by analyzing the activities of deletion derivatives in the two-hybrid system. UPF3 fragments were fused in frame to the lexA(DB), and the NMD2 fragment that contains the entire Upf3p-binding site, i.e., that from residue 564 to 1089 (Fig. 1) , was fused in frame to the GAL4(AD). As shown in Fig. 2 , coexpression of the GAL4(AD)-NMD2(564-1089) fusion with either the fulllength lexA(DB)-UPF3 fusion (Fig. 2, construct 1) or lex-A(DB)-UPF3 fusions containing N-terminal deletions of either 31 or 77 amino acids (Fig. 2, constructs 2 and 3 ) yielded substantial levels of ␤-galactosidase activity. A lexA(DB) fusion containing a deletion of 151 amino acids from the Upf3p N terminus led to a significant decrease of ␤-galactosidase activity (Fig. 2, construct 4) , and fusions containing deletions of either 204 or 279 amino acids from the Upf3p N terminus yielded background levels of ␤-galactosidase activity (Fig. 2 , constructs 5 and 6). Comparable effects of N-terminal deletions were observed with Upf3p fragments that also contain C-terminal truncations (Fig. 2, constructs 7 , 10, and 11 and constructs 8, 13, and 14). These results indicate that (i) two regions of Upf3p, from residue 78 to 151 and from residue 152 to 204, must contain important Nmd2p-interacting epitopes and (ii) the N-terminal 77 amino acids of Upf3p do not contribute to the interaction with Nmd2p, and their presence in the fusion proteins may inhibit such an interaction to some extent.
C-terminal deletions of UPF3 provided further definition of its Nmd2p-interacting domain. lexA(DB)-UPF3 fusions containing C-terminal deletions of 109 or 183 amino acids promoted almost twofold increases in ␤-galactosidase activity, relative to that of the full-length fusion (Fig. 2, constructs 7 and  8) , whereas the fusion containing a deletion of 236 amino acids from the Upf3p C terminus yielded background levels of ␤-galactosidase (Fig. 2, construct 9) . These results underscore the importance of Upf3p residues 152 to 204 in Nmd2p binding. Moreover, these results, and those demonstrating the consequences of C-terminal truncation of Upf3p fragments which also contain N-terminal deletions (Fig. 2, constructs 10 to 15) , further suggest that the C-terminal 109 amino acids of Upf3p do not contribute to Nmd2p interaction and may actually inhibit Nmd2p-Upf3p interaction. Taken together, the results in Fig. 2 indicate that the region of Upf3p from residue 78 to 204 is necessary for Nmd2p interaction.
Interactions between Upf3p and Nmd2p were also examined in constructs in which the lexA(DB) and GAL4(AD) fusions were reversed. Results essentially identical to those shown in Fig. 2 were obtained except that we did detect a weak interaction between lexA(DB)-NMD2(564-1089) and a GAL4(AD)-UPF3 fusion containing a deletion of 204 amino acids from its N terminus (the latter being the homolog of construct 5 in Fig.  2 ) (data not shown). This observation suggests that the region from Upf3p residue 205 to 279 may also contribute to Upf3-Nmd2p interaction, a conclusion further supported by the observation that the lexA(DB) fusion harboring UPF3 residues 78 to 278 demonstrated the highest level of ␤-galactosidase activity when tested for interaction with GAL4(AD)-NMD2(564-1089) (Fig. 2, construct 11) . Thus, we conclude that an internal region of Upf3p, comprised of residues 78 to 278, is the major determinant for interaction with Nmd2p.
The Zn 2؉ finger-like motifs in Upf1p are necessary but not sufficient for interaction with Nmd2p. We previously identified NMD2 as a gene encoding a Upf1p-interacting protein and localized its Upf1p-interacting domain to a 157-amino-acid segment at its carboxyl terminus (12, 14) . To determine the region(s) of Upf1p responsible for interaction with Nmd2p, we constructed a series of Upf1p deletion derivatives and tested their abilities to interact with Nmd2p in the two-hybrid system. Here, the UPF1-containing fragments were fused in frame to the GAL4(AD), and the NMD2 fragment that contains the entire Upf1p-interacting domain (residues 933 to 1089) was fused in frame to the GAL4(DB). As shown in Fig. 3 , coexpression of the GAL4(DB)-NMD2(933-1089) fusion with fulllength GAL4(AD)-UPF1 (Fig. 1, construct 1) or GAL4(AD) fusions harboring UPF1 fragments with C-terminal deletions up to residue 181 (Fig. 3, constructs 2 to 7) all led to the accumulation of substantial ␤-galactosidase activity. GAL4 (AD) fusions harboring internal UPF1 fragments from residues 62 to 289, 62 to 207, and 62 to 181 (Fig. 3, constructs 9 to 11) also showed significant two-hybrid activity, but that activity was three-to sixfold less than that of the aforementioned UPF1 fusions. This decrease in activity was specific for interaction with Nmd2p, since the same deletions had no effect on Upf1p homodimerization (12a). In contrast, no detectable ␤-galactosidase activity was observed when the GAL4(DB)-NMD2(933-1089) fusion was coexpressed with (i) a GAL4(AD) fusion harboring a UPF1 fragment with a C-terminal deletion up to residue 153 (Fig. 3, construct 8 ), (ii) GAL4(AD) fusions harboring UPF1 fragments with N-terminal deletions of either 290 or 556 residues (Fig. 3, constructs 13 and 14) , or (iii) GAL4(AD) fusions harboring internal UPF1 fragments from residues 62 to 153 (data not shown), 80 to 289 (Fig. 3, construct  12 ), 80 to 207, and 80 to 181 (data not shown). These results indicate that the N-terminal 181 amino acids of Upf1p contain the major determinant(s) for interaction with Nmd2p. This region includes, but is not limited to, amino acids comprising the Zn 2ϩ finger-like motifs within Upf1p (1, 18, 22) , indicating that they are essential but not sufficient for interaction with Nmd2p. These conclusions were substantiated by observations that internal deletions of Upf1p from residue 62 to 152 or 152 to 289 completely abolished Upf1p-Nmd2p interaction while deletions of residues 290 to 425, 426 to 553, 554 to 608, 609 to 789, and 790 to 806 had essentially no effect on such interaction (data not shown).
Upf1p and Upf3p interact in the two-hybrid system. Using the yeast two-hybrid system, we have characterized Upf1p-Nmd2p and Nmd2p-Upf3p interactions (see above and references 12 and 14). We were also interested in determining whether Upf1p-Upf3p interactions could be detected with this system, and we used two sets of constructs to test this possibility. In one experiment, we assayed the ability of a full-length lexA(DB)-UPF3 fusion to interact with a panel of GAL4(AD)-UPF1 fusions (Fig. 3, constructs 1 to 14) . When coexpressed with lexA(DB)-UPF3, all of the GAL4(AD)-UPF1 fusions that are capable of interacting with GAL4(DB)-NMD2(933-1089) yielded detectable levels of ␤-galactosidase activity (Fig. 3 , constructs 1 to 7 and 9 to 11). Of these, the highest levels of activity were observed with GAL4(AD) fusions containing UPF1 fragments from residues 1 to 666, 1 to 207, and 62 to 207 (Fig. 3, constructs 2, 6, and 10) . All of the GAL4(AD)-UPF1 fusions that are not capable of interacting with GAL4(DB)-NMD2(933-1089) yielded only background levels of ␤-galactosidase activity (Fig. 3, constructs 8 and 12 to 14) . These results suggest that Upf1p and Upf3p do interact in this assay and that the Upf3p-and Nmd2p-interacting domains within Upf1p overlap or are identical to each other.
We also tested the ability of the full-length GAL4(AD)-UPF1 fusion to interact with a panel of lexA(DB)-UPF3 fusions (Fig. 2, constructs 1 to 15 ). When coexpressed with full-length GAL4(AD)-UPF1, all but two of the lexA(DB)-UPF3 fusions that are capable of interacting with GAL4(AD)-NMD2(564-1089) accumulated ␤-galactosidase activity, although to considerably lesser extents (Fig. 2, constructs 1 to 4, 7, 10 , 11, and 13); all of the lexA(DB)-UPF3 fusions that do not interact with GAL4(AD)-NMD2(564-1089) yielded background levels of ␤-galactosidase activity (Fig. 2, constructs 5, 6, 9, 12, and 15) . These results indicate that Upf1-and Nmd2p-interacting domains within Upf3p also overlap or are identical to each other.
Two-hybrid interactions of Upf1p-Nmd2p, Nmd2p-Upf3p, and Upf1p-Upf3p in the absence of genomic UPF1, NMD2, or UPF3. The two-hybrid approach does not distinguish between direct and indirect interactions. For example, Upf3p could associate with Upf1p by using Nmd2p as a bridging molecule. We therefore repeated a subset of the previous two-hybrid assays with isogenic strains with UPF1, NMD2, or UPF3 individually deleted. Upf1p-Nmd2p and Nmd2p-Upf3p interactions were tested with the GAL4 (AD)-UPF1(1-971) UPF1(1-207) . These experiments showed that in upf1⌬ and upf3⌬ strains, all of the tested interactions occur as well as they do in wild-type cells ( Table 5 ), indicating that they do not require the UPF1 and UPF3 gene products. Likewise, deletion of the NMD2 gene had no effect on Upf1p-Nmd2p or Nmd2p-Upf3p interactions (Table 5) . However, nmd2⌬ cells were completely incapable of supporting either pair of Upf1p-Upf3p interactions (Tables 5  and 6 ). These results imply that Nmd2p can bind Upf1p and UPF1(1-207) (moderately strong interactors) were used to examine interactions between Upf1p and Upf3p. ␤-Galactosidase activity was determined qualitatively by replica plating on X-Gal-containing plates. ϩ, blue color development; Ϫ, no color development (after 7 days of incubation at 30ЊC).
Upf3p simultaneously and promote the formation of a Upf1p-Nmd2p-Upf3p complex in vivo.
Overexpression of Nmd2p enhances the formation of a Upf1p-Nmd2p-Upf3p complex. The data described above suggest that Nmd2p bridges the apparent interaction between Upf1p and Upf3p. To test this hypothesis further, we asked whether overexpression of Nmd2p could alter the extent of the Upf1p-Upf3p two-hybrid interaction. A series of plasmids expressing either full-length Nmd2p or fragments thereof were introduced into yeast cells coexpressing either of two pairs of fusion proteins, lexA(DB)-UPF3 . In the wild-type NMD2 background, the level of ␤-galactosidase activity was low for both pairs of interactors (although significantly better for the pair including truncated Upf1p) (Table  6 ). However, when full-length NMD2, or a fragment of NMD2 including residues 564 to 1089, was overexpressed, yeast strains containing both pairs of interactors showed approximately 10-to 100-fold increases in ␤-galactosidase activity. In contrast, overexpression of Nmd2p fragments that contain deletions of either the Upf1p-interacting domain (NMD2-C⌬166) or both the Upf1p-and Upf3p-interacting domains (NMD2-C⌬526) had no effect on the level of ␤-galactosidase activity (Table 6 ). These data indicate that overexpression of Nmd2p can enhance the formation of a Upf1p-Nmd2p-Upf3p complex in vivo and that this activity is dependent on the presence of intact Upf1p-and Upf3p-interacting domains within Nmd2p.
We also introduced a plasmid overexpressing a fragment of Nmd2p from residues 564 to 1089 into yeast strains containing the GAL4(AD)-UPF1(1-971) fusion and each of a panel of lexA(DB)-UPF3 fusions (Fig. 2, constructs 1 to 15 ). As shown in Fig. 2 , levels of ␤-galactosidase activity were significantly increased in yeast strains expressing lexA(DB)-UPF3 fusion proteins previously shown to be capable of interacting with Nmd2p (Fig. 2, constructs 1 to 4, 7, 8, 10, 11, 13, and 14) . However, levels of ␤-galactosidase activity were not increased in yeast strains expressing lexA(DB)-UPF3 fusion proteins previously shown to be incapable of interacting with Nmd2p (Fig.  2, constructs 5, 6, 9, 12, and 15 ). This indicates that the formation of a Upf1p-Nmd2p-Upf3p complex is also dependent on the ability of Upf3p to interact with Nmd2p. Comparable experiments showed that UPF1 deletions that disrupt of the ability of Upf1p to interact with Nmd2p also abolish complex formation (data not shown). Collectively, these results reinforce the conclusion that Nmd2p is a bridging molecule and that the two-hybrid Upf1p-Upf3p interaction must be indirect.
Single or multiple deletions of UPF1, NMD2, and UPF3 inhibit nonsense-mediated mRNA decay to the same extent. The results of our two-hybrid analyses (see above and references 12 and 14) strongly suggest that Upf1p, Nmd2p, and Upf3p function either as a complex or in closely related steps of the nonsense-mediated mRNA decay pathway. This conclusion was strengthened by analyzing the nonsense-mediated mRNA decay phenotypes associated with single or multiple deletions of the genes encoding each of these proteins. To this end, we constructed yeast strains containing either single deletions of UPF1, NMD2, and UPF3, double deletions of UPF1/ NMD2, NMD2/UPF3, and UPF1/UPF3, or a triple deletion of all three genes (see Materials and Methods). Total RNA was isolated from yeast strains containing these deletions, and Northern blot analysis was used to monitor the levels of the CYH2 pre-mRNA, an endogenous nonsense-containing mRNA (12, 13) . Northern analysis demonstrated that the abundance of the CYH2 pre-mRNA increased to equal extents in strains carrying the single deletions, the double deletions, or the triple deletion (Fig. 4) .
Both the N-terminal Upf3p-binding site and a region including residues 772 to 816 of Nmd2p are required for dominant inhibition of nonsense-mediated mRNA decay. We have previously shown that overexpression of a GAL4(AD) fusion to a 764-amino-acid C-terminal fragment of Nmd2p can inhibit the nonsense-mediated mRNA decay pathway in a dominant manner when the fusion protein is localized to the cytoplasm but not when it is localized to the nucleus (12) . Recently, we demonstrated that the dominant-negative effects of this nmd2 allele are independent of its Upf1p-binding activity, since a deletion of the entire Upf1p-interacting domain of Nmd2p had no effect on the inhibition of mRNA decay (14) . To determine the region(s) responsible for the dominant-negative effects, we examined the inhibitory activity of the panel of NMD2 fragments shown in Fig. 1A . Each of these fragments was cloned into an expression vector and overexpressed in an NMD2 wildtype strain as described previously (14) . Northern blot analysis of the relative levels of the CYH2 pre-mRNA and mRNA was used to monitor the activity of the nonsense-mediated mRNA decay pathway in each of the transformants. As shown in Fig.  1A and C, N-terminal deletions of Nmd2p up to residue 563 have no significant effects on dominant-negative activity (constructs 1 to 3). However, N-terminal deletions extending to residue 771 lead to a complete loss of inhibitory activity (Fig.  1A and C constructs 4 to 6), indicating that the region spanning residues 564 to 771 is required for dominant inhibition. NMD2 fragments containing C-terminal deletions up to residue 816 still inactivated nonsense-mediated mRNA decay as efficiently as the original dominant-negative nmd2 allele (Fig. 1A and C, compare construct 1 to constructs 10 to 12 and 18 to 20), indicating that the region from residue 817 to 1089, which includes the entire acidic domain and the entire Upf1p-interacting domain of Nmd2p, is not required for dominant inhibition. In contrast, further C-terminal deletions up to Nmd2p residue 771 lead to a complete loss of inhibitory activity (Fig.  1A and C, constructs 13, 14, 21, and 22) , indicating that the , a construct that encodes a 526-amino-acid deletion from the Nmd2p C terminus. NMD2 and its derivatives contain N-terminal triple-HA tags, and their expression was driven by the ADH1 promoter on a centromere-based vector, pRS313. Individual transformants were selected, and ␤-galactosidase activity was determined quantitatively in a liquid assay. ␤-Galactosidase activities from wild-type (NMD2) and nmd2⌬ strains are also shown. Values represent the means Ϯ standard deviations for at least three independent assays performed on cultures derived from individual colonies.
region from residue 772 to 816 is also required for dominant inhibition.
Although residues 564 to 771 and 772 to 816 are required for dominant inhibition, overexpression of NMD2 fragments containing either region alone is not sufficient to inactivate nonsense-mediated mRNA decay (Fig. 1A and C, constructs 6 and 22) . Because the NMD2 fragment containing both regions can inactivate nonsense-mediated mRNA decay efficiently (Fig. 1A  and C, construct 20) , we conclude that the Nmd2p domain encompassing residues 564 to 816 is responsible for the dominant-negative effect. Interestingly, this region spans residues that are required (residues 564 to 771) as well as residues that are not required (residues 772 to 816) for Nmd2p binding to Upf3p (see above).
Overexpression of Upf3p alone is not sufficient to alleviate the dominant-negative effects of Nmd2 DN p. Since the minimal dominant-negative fragment of Nmd2p includes a Upf3p-binding site (see above), it is formally possible that the dominantnegative effect is attributable to the saturation of functional Upf3p with nonfunctional Nmd2p. To test this possibility, we transformed a series of plasmids expressing UPF3 or epitopetagged UPF3 into yeast cells containing a dominant-negative nmd2 allele. The results of these experiments are shown in Fig.   5 . In cells containing the dominant-negative nmd2 allele, expression of UPF3 from a single-copy or a high-copy-number plasmid had no effect on dominant-negative inhibition (Fig.  5B, lanes 3 and 4) . Furthermore, there was no effect on dominant inhibition when Upf3p expression from a high-copynumber plasmid was enhanced by replacing the normal UPF3 promoter with the more potent ADH1 promoter (Fig. 5B, lanes  5 and 6) . In contrast, expression of NMD2 from a single-copy or a high-copy-number plasmid or expression of HA-NMD2 from the ADH1 promoter on a high-copy-number plasmid led to a dosage-dependent increase of nonsense-mediated mRNA decay activity (Fig. 5A, lanes 3 to 5) . These results indicate that the dominant-negative effect of Nmd2p is targeted to another interacting component that is distinct from Upf3p.
DISCUSSION
Nonsense-mediated mRNA decay is dependent on the activity of the interacting components Upf1p, Nmd2p, and Upf3p. UPF1, NMD2/UPF2, and UPF3 are the three principal nonessential genes whose products have been shown to be required for the selective decay of only those transcripts in S. cerevisiae that contain premature translational termination codons (for a review, see reference 16). While structural and biochemical analyses suggest that Upf1p may be an RNA-binding protein with ATPase and RNA helicase activities (1, 7, 18, 22) , little else is known about the functions of these factors. As an approach to elucidating their respective roles in mRNA decay, we have begun to identify the proteins with which these factors interact and to define the relevant interacting domains. Thus, in earlier studies, we showed that Upf1p and Nmd2p are interacting proteins, localized the Upf1p-interacting domain of Nmd2p to its 157-amino-acid C terminus, demonstrated that interaction between Upf1p and Nmd2p is required for nonsense-mediated mRNA decay, and established that at least one other factor must interact with Nmd2p (12, 14) . Here, we sought to identify the other factor(s) and used the yeast twohybrid system to show that both UPF1 and UPF3 encode Nmd2p-interacting proteins and that NMD2 encodes a Upf3p-interacting protein (12a) . Interactions between Nmd2p and Upf3p have also been reported recently (37) . Further evidence for these interactions was provided by experiments that defined specific Nmd2p-interacting domains within Upf1p and Upf3p and specific Upf1p-and Upf3p-interacting domains within Nmd2p (Fig. 1 to 3) , as well as by experiments which showed that cells harboring single or multiple deletions of UPF1, NMD2, and UPF3 inhibit nonsense-mediated mRNA decay to the same extent (Fig. 4) (5, 12, 19) . Collectively, these data demonstrate that Upf1p, Nmd2p, and Upf3p are interacting components of the yeast nonsense-mediated mRNA decay pathway.
Two-hybrid interactions between Upf1p and Upf3p are indirect and are bridged by Nmd2p. Our two-hybrid analyses identified Upf1p-Nmd2p, Nmd2p-Upf3p, and Upf1p-Upf3p interactions ( Fig. 1 to 3) (12, 14) . To determine whether the observed pairwise interactions require the respective third components, we examined the consequences that deleting genomic copies of UPF1, NMD2, and UPF3 had on the outcome of two-hybrid experiments. We find that single deletion of UPF1, NMD2, or UPF3 has no effect on Upf1p-Nmd2p or Nmd2p-Upf3p interactions, indicating that they occur without the participation of the absent factor (Table 5 ). However, deletion of NMD2 completely abolishes the apparent interaction between Upf1p and Upf3p (Tables 5 and 6 ), indicating that this interaction in wild-type cells is indirect and is bridged by Nmd2p. Further evidence for this conclusion includes the   FIG. 4 . Single or multiple deletions of UPF1, NMD2, and UPF3 have identical nonsense-mediated mRNA decay phenotypes. Total RNA was isolated from yeast cells containing single or multiple deletions of UPF1, NMD2, and UPF3. The construction of these strains is described in Materials and Methods. Northern blotting was performed as described in the legend to Fig. 1 . CYH2 premRNA/mRNA ratios from these cells are summarized. WT, wild type.
following: (i) overexpression of either full-length Nmd2p or its dominant-negative fragment enhances the apparent interaction of Upf1p and Upf3p by 10-to 200-fold (Table 6 and Fig. 2); (ii) this enhancement is dependent on the presence of intact Upf1p-and Upf3p-interacting domains within Nmd2p and on the ability of Upf1p and Upf3p to interact with Nmd2p (Table  6 and Fig. 2 and data not shown); (iii) the domains of Upf1p and Upf3p putatively involved in the interaction with each other correspond to the domains on the two proteins which interact with Nmd2p ( Fig. 2 and 3) ; and (iv) a two-hybrid screen with Upf1p as bait failed to identify Upf3p as a Upf1p-interacting protein, and a two-hybrid screen with Upf3p as bait failed to identify Upf1p as a Upf3p-interacting protein, but both screens identified Nmd2p an interacting partner (12, 12a) . The fact that Nmd2p is required for the observed interaction between Upf1p and Upf3p indicates that Nmd2p can interact with both Upf1p and Upf3p simultaneously and that it may promote the formation of a Upf1p-Nmd2p-Upf3p complex in vivo. Experiments demonstrating that all three proteins are predominantly localized to the cytoplasm support this possibility (3, 12b, 26) , but coimmunoprecipitation or cross-linking experiments are necessary for definitive identification of such a complex.
When assaying the two-hybrid interactions between Upf1p and Upf3p in NMD2 wild-type cells, we observed that a subset of truncations in either Upf1p or Upf3p led to a significant increase of ␤-galactosidase activity (Fig. 2, constructs 2, 3, 7 , 10, and 11; Fig. 3, constructs 2, 6 , and 10). Each of these Upf1p or Upf3p fragments led to considerably more ␤-galactosidase activity than the respective full-length polypeptide. Such increases may simply reflect the loss of polypeptide sequences that interfere with two-hybrid interactions (e.g., masking domains or possible cytoplasmic retention signals), or they may indicate that binding of these Upf1p or Upf3p fragments to Nmd2p results in a conformational change in Nmd2p that, in turn, promotes increased binding of Nmd2p to Upf3p or Upf1p. The enhancement of Upf3p interaction by some Nterminal deletions of Nmd2p may be attributable to similar effects (Fig. 1, constructs 3 and 18) .
Novelty of the protein domains involved in Upf1p-Nmd2p and Nmd2p-Upf3p interactions. To delineate the domains essential for Upf1p-Nmd2p and Nmd2p-Upf3p interactions, we and YEplac112-ADH1p-FLAG-UPF3; lane 6, HFY1200 harboring pACTII-NMD2 DN and YEplac112-ADH1p-HA-UPF3. CYH2 pre-mRNA/mRNA ratios from these cells are summarized below the blot. S.C., single copy; H.C., high copy. used qualitative and quantitative two-hybrid analysis of deletion mutants of the respective genes. These experiments indicate the following. (i) None of the interacting domains identified in this study has significant sequence homology with known protein-protein interaction motifs, except for the Nmd2p-interacting domain of Upf1p and a weaker Upf3p-interacting domain of Nmd2p (see below). They may thus represent new classes of such structures. (ii) Upf1p and Upf3p interact with distinct domains of Nmd2p. The Upf1p-interacting domain of Nmd2p was previously mapped to a 157-aminoacid segment at its C terminus in which two regions, spanning residues 947 to 985 and 1034 to 1061, appear to be the principal Upf1p-interacting epitopes (14) . The major Upf3p-interacting domain is located within Nmd2p residues 564 to 771, and a weaker domain is localized to a region from residue 879 to 933. The latter domain, which includes almost all of the hyperacidic domain of Nmd2p (12) , enhances binding to Upf3p (Fig. 1A, constructs 10 and 18 ) but also appears to inhibit interaction with Upf1p (14) . Hyperacidic domains have been found in a number of other proteins, such as nucleolins and transcription factors, and their functions are largely unknown (17) . If the hyperacidic domain is actually involved in regulating Nmd2p-Upf3p interaction, it is likely to do so via interaction with a region of clustered positive charge in Upf3p.
In this regard, it should be noted that in a two-hybrid assay for interaction with the hyperacidic domain of Nmd2p, the Cterminal 256-amino-acid segment of Upf3p, which contains multiple lysine-argine-rich regions (19) , yielded the same level of ␤-galactosidase activity as did full-length Upf3p (data not shown). (iii) The Zn 2ϩ finger-like motifs of Upf1p, encompassed within residues 62 to 152 (1, 22) , are necessary but not sufficient for interaction with Nmd2p. Deletion analysis indicates that residues 62 to 181, which include the two Zn 2ϩ finger motifs and a short flanking region, comprise the minimal domain sufficient for interaction with Nmd2p (Fig. 3) . Although Zn 2ϩ finger motifs in other proteins have been implicated in both DNA and RNA binding (4), our results indicate that these motifs are also involved in both heterodimerization with Nmd2p (see above) and homodimerization (12a). This region of Upf1p, like that recently identified in the RAG1 protein (29) , thus may represent a structure that is distinct from that of the classical Zn 2ϩ finger motif and may exemplify a new class of protein-protein interaction domains. Dominant-negative Nmd2p targets a factor other than Upf1p or Upf3p. Overexpression of a protein comprised of a 764-amino-acid C-terminal fragment of Nmd2p fused to the GAL4(AD) has a dominant-negative effect on nonsense-mediated mRNA decay when the protein is localized in the cytoplasm but not when it is localized in the nucleus (12) . Since deletion or point mutations in the Upf1p-interacting domain of this fragment, or overexpression of Upf1p, do not alter dominant-negative inhibition, we have concluded that the inhibitory effects on mRNA decay arise from Nmd2p interaction with a factor other than Upf1p (14) . Further deletion mapping has shown that two regions of Nmd2p, spanning residues 564 to 771 and 772 to 816, are required for dominant-negative activity and that neither domain alone is sufficient for such activity (Fig. 1A and C) . Because these regions essential to the dominant-negative activity of Nmd2p include the principal Upf3p-interacting domain (Fig. 1A) , it is formally possible that the dominant-negative effect is attributable to the saturation of functional Upf3p with nonfunctional Nmd2p. However, two observations indicate that the dominant-negative fragment of Nmd2p must target a factor other than Upf3p: (i) overexpression of Upf3p does not reverse the dominant inhibition (Fig.  5) , and (ii) there is no correlation between the efficiency with which Nmd2p fragments bind Upf3p in the two-hybrid assay and the extent of dominant-negative inhibition by the same fragments (Fig. 1) .
The simplest explanation for these observations is that both the principal Upf3p-interacting domain (residues 564 to 771) and the region from residue 772 to 816 may contribute to the binding of yet another factor and that overexpression of the dominant-negative Nmd2p fragment leads to titration of only that unidentified factor. Alternative explanations include the possibility that the region from residue 772 to 816 is part of the binding site for a novel factor and that both this factor and Upf3p are simultaneously titrated by overexpression of dominant-negative Nmd2p. A variation on the latter hypothesis suggests that binding of the novel factor to Nmd2p may require the presence of Upf3p. Clearly, further characterization of the genes identified in the two-hybrid screen in which the nmd2 dominant-negative fragment was used as bait may help to elucidate the mechanism in question.
